Entourage Health Corp.
ETRGF · OTC
9/30/2024 | 6/30/2024 | 3/31/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Revenue | $10 | $9 | $13 | $10 |
| % Growth | 3% | -27.1% | 27.6% | – |
| Cost of Goods Sold | $7 | $8 | $7 | $14 |
| Gross Profit | $3 | $1 | $6 | -$4 |
| % Margin | 30.1% | 12.9% | 46.9% | -44% |
| R&D Expenses | $0 | $0 | $0 | -$0 |
| G&A Expenses | $3 | $4 | $5 | $4 |
| SG&A Expenses | $4 | $5 | $5 | $6 |
| Sales & Mktg Exp. | $1 | $1 | $1 | $1 |
| Other Operating Expenses | -$0 | -$4 | $0 | -$0 |
| Operating Expenses | $4 | $1 | $6 | $4 |
| Operating Income | -$1 | -$4 | $0 | -$9 |
| % Margin | -12.2% | -38% | 3% | -88.2% |
| Other Income/Exp. Net | -$7 | -$7 | -$7 | -$8 |
| Pre-Tax Income | -$8 | -$10 | -$6 | -$17 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$8 | -$10 | -$6 | -$17 |
| % Margin | -87.7% | -111.5% | -49.5% | -172.5% |
| EPS | -0.027 | -0.034 | -0.02 | -0.056 |
| % Growth | 19.1% | -64.2% | 63.4% | – |
| EPS Diluted | -0.027 | -0.034 | -0.02 | -0.056 |
| Weighted Avg Shares Out | 308 | 308 | 308 | 308 |
| Weighted Avg Shares Out Dil | 308 | 308 | 308 | 308 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $6 |
| Interest Expense | $7 | $7 | $7 | $6 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$1 | -$3 | $1 | -$10 |
| % Margin | -11.8% | -36.8% | 4.2% | -105.4% |